Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Obsessive-compulsive Disorder With Acute Onset”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Post-approval studies (Phase 4)UnknownNCT03348618
What this trial is testing

Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)

Who this might be right for
Pediatric Acute-Onset Neuropsychiatric SyndromePediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections
IMMUNOe Research Centers 21
Not applicableStudy completedNCT02190292
What this trial is testing

PANS - A Detailed Study of the Patients, Their Symptoms, Biomarkers and Treatment Offered in a Scandinavian Cohort

Who this might be right for
Obsessive-compulsive Disorder With Acute OnsetPANDASPediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections+3 more
Karolinska Institutet 185
Not applicableEnded earlyNCT03507218
What this trial is testing

Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS)

Who this might be right for
Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)
National Institute of Mental Health (NIMH) 9
Not applicableLooking for participantsNCT04806620
What this trial is testing

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Who this might be right for
Post-Acute COVID-19 SyndromeME/CFSRheumatic Arthritis+41 more
Brain Inflammation Collaborative 10,000